AlmegaPL (Nannochloropsis oculata Algae)

AlmegaPL (Nannochloropsis oculata microalgae extract) is characterized by a phospholipid-bound omega-3 fatty acid matrix, which distinguishes it from standard fish oil or algal oil triglyceride forms. Key bioactive components include: EPA (eicosapentaenoic acid) as the dominant omega-3, delivered primarily in phospholipid form (phosphatidylcholine and phosphatidylethanolamine bound), which enhances intestinal absorption and lymphatic transport compared to triglyceride-bound EPA — bioavailability studies suggest phospholipid-bound EPA achieves superior incorporation into red blood cell membranes and plasma at lower doses. DHA is present in minor amounts, as Nannochloropsis species are EPA-dominant. The extract also contains glycolipids and betaine lipids native to the microalgae cell membrane. Carotenoid content includes violaxanthin and zeaxanthin, both naturally occurring in Nannochloropsis oculata, with antioxidant and potential anti-inflammatory roles. Chlorophyll derivatives are present in small quantities. Protein content in the whole algae biomass is approximately 25–35% by dry weight, though the AlmegaPL extract is lipid-fraction concentrated, reducing protein contribution in the final ingredient. Mineral content from the source algae includes iodine, calcium, magnesium, and iron, though concentrations in the extracted lipid fraction are minimal. The phospholipid delivery matrix is the primary distinguishing nutritional feature, enabling lower effective doses (typically 1–1.5g/day in clinical studies) to produce measurable omega-3 index increases compared to standard fish oil formulations.